Adjuvant chemotherapy, early breast cancer and positive bone scan
Fox, R.M.; Adiseshan, N.
Medical Journal of Australia 1(10): 347-348
1977
ISSN/ISBN: 0025-729X PMID: 859477 Document Number: 119516
Document emailed within 1 workday
Related Documents
Perez, E.; Muss, H.B. 2005: Optimizing adjuvant chemotherapy in early-stage breast cancer Oncology 19(14): 1759-1767; Discussion 1768: 1772-1774; 1777-1778Sutepvarnon, A.; Warnnissorn, M.; Srimuninnimit, V. 2013: Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer Journal of the Medical Association of Thailand 96(Suppl 2): S60-S66
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
2006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597
Altundag, K. 2018: Concurrent administration of aromatase inhibitors with chemotherapy might show better outcome in high risk hormone-receptor positive early-stage breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1559-1560
Bell, R.L. 1975: The bone scan in the breast cancer patient Journal of the Tennessee Medical Association 68(10): 806
Biersack, H.J.; Kozak, B.; Winkler, C.; Hartlapp, A. 1985: Bone scan in metastasizing breast cancer Deutsche Medizinische Wochenschrift 110(3): 116-117
Semiglazov, V.F.; Golubeva, O.M.; Bavli, I.L.; Ivanova, O.A.; Topuzov, E.E. 1992: The adjuvant chemotherapy of breast cancer Voprosy Onkologii 38(10): 1187-1194
Singhal, N.; Bapsy, P.P. 2003: Breast cancer and adjuvant chemotherapy National Medical Journal of India 16(4): 214-215
Rouëssé, J.; May-Levin, F.; Sarrazin, D.; Petit, J.Y. 1978: Adjuvant chemotherapy of breast cancer La Revue du Praticien 28(13): 977-983
Kennedy, B.J. 1979: Adjuvant chemotherapy of breast cancer Minnesota Medicine 62(7): 509-511
Mattheiem, W.; Philippon, R.; Heuson, J.C. 1971: Adjuvant chemotherapy in breast cancer Acta Chirurgica Belgica Suppl 1: 105-111
Evans, R.A. 1995: Adjuvant chemotherapy in breast cancer New England Journal of Medicine 333(9): 596-597
Russell, I.S. 1977: Adjuvant chemotherapy in the treatment of breast cancer Australian Family Physician 6(6): 629-635
Tahover, E.; Sonnenblick, A.; Peretz, T.; Katz, D. 2012: Update: adjuvant trastuzumab in HER2 positive breast cancer Harefuah 151(1): 37-42 61
Jungi, W.F. 1984: Adjuvant chemotherapy in breast cancer: status in 1984 Wiener Klinische Wochenschrift 96(13): 486-492
Salvadori, B.; Celio, L.; Oriana, R.; Bajetta, E. 2000: Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: long-term results of an experience at the Milan Cancer Institute Tumori 86(3): 258-259
Müller, H. 1990: Effects of adjuvant chemotherapy of breast cancer on gonadal function Zentralblatt für Gynakologie 112(13): 795-801